Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018 (2018), Article ID 8968573, 10 pages
https://doi.org/10.1155/2018/8968573
Research Article

Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model

1Department of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China
2Zhejiang Provincial Top Key Discipline in Surgery, Wenzhou Key Laboratory of Surgery, Department of Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China
3Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China

Correspondence should be addressed to Bicheng Chen; moc.361@hcnosib and Hong Zhu; moc.621@mfnyyyw

Received 22 September 2017; Revised 8 December 2017; Accepted 24 December 2017; Published 13 March 2018

Academic Editor: Mark Yorek

Copyright © 2018 Xuehai Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Xue, D. Gui, L. Zheng, R. Zhai, F. Wang, and N. Wang, “Mechanistic insight and management of diabetic nephropathy: recent progress and future perspective,” Journal of Diabetes Research, vol. 2017, Article ID 1839809, 7 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Yokoyama and T. Deckert, “Central role of TGF-β in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis,” Diabetic Medicine, vol. 13, no. 4, pp. 313–320, 1996. View at Publisher · View at Google Scholar
  3. A. L. Lima, T. Illing, S. Schliemann, and P. Elsner, “Cutaneous manifestations of diabetes mellitus: a review,” American Journal of Clinical Dermatology, vol. 18, no. 4, pp. 541–553, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. A. G. Tzakis, Y. Zeng, J. J. Fung et al., “Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement,” The Lancet, vol. 336, no. 8712, pp. 402–405, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. T. C. Lee, N. R. Barshes, C. A. O'Mahony et al., “The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy,” Transplantation Proceedings, vol. 37, no. 5, pp. 2263–2265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Health Quality Ontario, “Pancreas islet transplantation for patients with type 1 diabetes mellitus: a clinical evidence review,” Ontario Health Technology Assessment Series, vol. 15, no. 16, pp. 1–84, 2015. View at Google Scholar
  7. Y. He, Z. Xu, M. Zhou et al., “Reversal of early diabetic nephropathy by islet transplantation under the kidney capsule in a rat model,” Journal of Diabetes Research, vol. 2016, Article ID 4157313, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Gewurz, X. H. Zhang, and T. F. Lint, “Structure and function of the pentraxins,” Current Opinion in Immunology, vol. 7, no. 1, pp. 54–64, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Lech, C. Rommele, and H. J. Anders, “Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3,” Nephrology, Dialysis, Transplantation, vol. 28, no. 4, pp. 803–811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. Nauta, S. de Haij, B. Bottazzi et al., “Human renal epithelial cells produce the long pentraxin PTX3,” Kidney International, vol. 67, no. 2, pp. 543–553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Presta, M. Camozzi, G. Salvatori, and M. Rusnati, “Role of the soluble pattern recognition receptor PTX3 in vascular biology,” Journal of Cellular and Molecular Medicine, vol. 11, no. 4, pp. 723–738, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Rovere, G. Peri, F. Fazzini et al., “The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells,” Blood, vol. 96, no. 13, pp. 4300–4306, 2000. View at Google Scholar
  13. B. Bussolati, G. Peri, G. Salvidio, D. Verzola, A. Mantovani, and G. Camussi, “The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells,” The Journal of Immunology, vol. 170, no. 3, pp. 1466–1472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Lech, C. Römmele, R. Gröbmayr et al., “Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury,” Kidney International, vol. 83, no. 4, pp. 647–661, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Sun, J. Tian, W. Xian, T. Xie, and X. Yang, “Pentraxin-3 attenuates renal damage in diabetic nephropathy by promoting M2 macrophage differentiation,” Inflammation, vol. 38, no. 5, pp. 1739–1747, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. E. J. Zmuda, C. A. Powell, and T. Hai, “A method for murine islet isolation and subcapsular kidney transplantation,” Journal of Visualized Experiments, no. 50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Lembert, J. Wesche, P. Petersen, M. Doser, H. D. Becker, and H. P. Ammon, “Areal density measurement is a convenient method for the determination of porcine islet equivalents without counting and sizing individual islets,” Cell Transplantation, vol. 12, no. 1, pp. 33–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Napoli, A. M. Davalli, M. F. Hirshman, R. Weitgasser, G. C. Weir, and E. S. Horton, “Islet transplantation under the kidney capsule fully corrects the impaired skeletal muscle glucose transport system of streptozocin diabetic rats,” Journal of Clinical Investigation, vol. 97, no. 6, pp. 1389–1397, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. G. H. Tesch and T. J. Allen, “Rodent models of streptozotocin-induced diabetic nephropathy (methods in renal research),” Nephrology, vol. 12, no. 3, pp. 261–266, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Usuelli and E. La Rocca, “Novel therapeutic approaches for diabetic nephropathy and retinopathy,” Pharmacological Research, vol. 98, pp. 39–44, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. H. K. Yang and K. H. Yoon, “Current status of encapsulated islet transplantation,” Journal of Diabetes and its Complications, vol. 29, no. 5, pp. 737–743, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Chen, W. W. Zhang, K. H. Chen et al., “Urinary DcR2 is a novel biomarker for tubulointerstitial injury in patients with diabetic nephropathy,” American Journal of Physiology-Renal Physiology, vol. 313, no. 2, pp. F273–F281, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Sjoberg, A. R. Qureshi, B. Anderstam, A. Alvestrand, and P. Barany, “Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation,” Blood Purification, vol. 34, no. 3-4, pp. 290–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Suliman, M. I. Yilmaz, J. J. Carrero et al., “Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 4, pp. 976–985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. I. Yilmaz, J. Axelsson, A. Sonmez et al., “Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 3, pp. 535–541, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Chen, M. M. Matzuk, X. J. Zhou, and L. CY, “Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury,” Kidney International, vol. 82, no. 11, pp. 1195–1207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. M. Speeckaert, R. Speeckaert, J. J. Carrero, R. Vanholder, and J. R. Delanghe, “Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease,” Journal of Clinical Immunology, vol. 33, no. 5, pp. 881–890, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Kunes, V. Lonsky, J. Mand'ak et al., “Essential PTX3 biology (not only) for cardiologists and cardiac surgeons,” Acta Medica, vol. 50, no. 1, pp. 29–33, 2007. View at Google Scholar
  29. Y. Xiao, N. Yang, Q. Zhang, Y. Wang, S. Yang, and Z. Liu, “Pentraxin 3 inhibits acute renal injury-induced interstitial fibrosis through suppression of IL-6/Stat3 pathway,” Inflammation, vol. 37, no. 5, pp. 1895–1901, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Celik, M. I. Yilmaz, S. Balta et al., “The relationship between plasma whole blood viscosity and cardiovascular events in patients with chronic kidney disease,” Clinical and Applied Thrombosis/Hemostasis, vol. 23, no. 6, pp. 663–670, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. R. C. Blantz and P. Singh, “Glomerular and tubular function in the diabetic kidney,” Advances in Chronic Kidney Disease, vol. 21, no. 3, pp. 297–303, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Q. Zhang, J. J. Dong, T. Cai, X. Shen, X. J. Zhou, and L. Liao, “High glucose induces apoptosis via upregulation of Bim expression in proximal tubule epithelial cells,” Oncotarget, vol. 8, no. 15, pp. 24119–24129, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Odonkor and S. Achilefu, “Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy,” Cancer Investigation, vol. 27, no. 4, pp. 417–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. O. D. Ortega-Hernandez, N. Bassi, Y. Shoenfeld, and J. M. Anaya, “The long pentraxin 3 and its role in autoimmunity,” Seminars in Arthritis and Rheumatism, vol. 39, no. 1, pp. 38–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Deyab, I. Hokstad, J. E. Whist et al., “Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis,” PLoS One, vol. 12, no. 2, article e0169830, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Schwarz, M. Simons, J. Reiser et al., “Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin,” Journal of Clinical Investigation, vol. 108, no. 11, pp. 1621–1629, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Tabatabaeifar, T. Wlodkowski, I. Simic et al., “An inducible mouse model of podocin-mutation-related nephrotic syndrome,” PLoS One, vol. 12, no. 10, article e0186574, 2017. View at Publisher · View at Google Scholar · View at Scopus